Halaven 0.44mg Injection (Eribulin mesylate)
Prescription RequiredManufactured By
Eisai pharmaceuticals india pvt ltd
Pack Of
1
Salt Composition
Eribulin mesylate
Storage
Keep in cold place
Overview
Halaven 0.44mg Injection is an anticancer medicine used for breast cancer and Liposarcoma. Injection active drug composition is Eribulin mesylate which is classified as microtubule dynamics inhibitor.
It works by binding to tubulin, inhibiting their growth, disrupting cell division and ultimately leading to the death of cancer cells. Always follow the prescribed dosage as recommended by the healthcare professional.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | halaven |
| Generic / Active Ingredient | Eribulin mesylate |
| Strength | 0.44 |
| Dosage Form | Injection |
| Manufacturer / Marketer | eisai pharmaceuticals india pvt ltd |
| Pack Size | 1 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | Breast Cancer |
Uses and Indications
Breast Cancer
Side Effects of Halaven 0.44mg Injection
Like all anti-cancer medications, Halaven 0.44mg Injection (Eribulin mesylate) may cause certain side effects. This occurs because medicine targets the tumor but also affects some healthy cells in the body. It is essential to be aware of some side effects to manage the disease effectively.
Common ones include:
● Low white blood cells
● Low red blood cell
● Low platelet
● Fatigue
● Weakness
● Fever
● Headache
● Nausea
● Vomiting
● Constipation
● Diarrhea
● Loss of appetite
Halaven 0.44mg Injection Dosage and How To Take It
Halaven 0.44mg Injection (Eribulin mesylate) should be taken under doctor prescription. The injection is taken through the skin in veins by a nurse or healthcare provider in a clinical setting, ensuring proper dosage and monitoring to minimize the risk of side effects.
It should be taken with food to improve the absorption level in the body. Do not take this medicine on your own to avoid complications during treatment.
Safety Advice for Halaven 0.44mg Injection
- ● Alcohol: Alcohol is strictly prohibited during the treatment because it increases the risk of unwanted side effects and health complications. Doctors do not recommend taking alcohol while using Halaven 0.44mg injection (Eribulin mesylate).
- ● Driving: It is unknown that Eribulin 0.44mg Injection (Halaven) caused dizziness but in case if you experience sleepiness then avoid driving and working on machinery while taking the medication.
- ● Pregnancy: Eribulin 0.44mg Injection (Halaven) is not prescribed for pregnant woman as it may harm the fetus because of its high potency, and therefore should only be used under strict medical supervision.
- ● Breastfeeding: Women who breastfeed, should avoid using Halaven 0.44mg Injection (Eribulin mesylate) because the medication is passed through the breast which harm the baby in many ways.
- ● Kidney: Eribulin 0.44mg Injection (Halaven) is not recommended for kidney patients because it may interfere with kidney function.
- ● Liver: Eribulin 0.44mg Injection (Halaven) is not prescribed to liver patients with severe liver problems because impaired liver function can affect how the medicine is processed in the body.
FAQs About Halaven 0.44mg Injection
1. Who can take Halaven 0.44mg Injection (Eribulin mesylate)?
Halaven 0.44mg injection is taken by the patient with breast cancer and liposarcoma. The medicine is used as a primary approach towards the treatment.
2. Can I take Halaven 0.44mg Injection with other treatment as well?
Consult the doctor before taking Eribulin 0.44mg Injection (Halaven) with other treatment to ensure safety and effectiveness.
3. Is Halaven 0.44mg Injection immunotherapy or chemotherapy?
Halaven 0.44mg Injection is a type of chemotherapy, used with other medicine as well to improve the drug's effectiveness.
4. How does breast cancer spread in the body?
The cancer grows into nearby tissues of the chest and breast and can surrounding lymph nodes, particularly under the arm and then reach to other parts such as bones, lungs, liver or brain through the blood.
5. What is Halaven 0.44mg Injection (Eribulin mesylate) salt composition?
Halaven 0.44mg Injection's active ingredient is Eribulin mesylate, which is the salt form, used to reduce the growth of cancer cells in the body.
References
● Huyck, T. K., Gradishar, W., Manuguid, F., & Kirkpatrick, P. (2011). Eribulin mesylate. Nature reviews drug discovery, 10(3), 173.
Jain, S., & Vahdat, L. T. (2011). Eribulin mesylate. Clinical Cancer Research, 17(21), 6615-6622.
● Dybdal-Hargreaves, N. F., Risinger, A. L., & Mooberry, S. L. (2015). Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent. Clinical Cancer Research, 21(11), 2445-2452.
● Mukohara, T., Nagai, S., Mukai, H., Namiki, M., & Minami, H. (2012). Eribulin mesylate in patients with refractory cancers: a Phase I study. Investigational new drugs, 30(5), 1926-1933.
● Cortes, J., Schöffski, P., & Littlefield, B. A. (2018). Multiple modes of action of eribulin mesylate: Emerging data and clinical implications. Cancer treatment reviews, 70, 190-198.
Marketer Details
Eisai pharmaceuticals india pvt ltd
Author Details
Written By:
Nonish Sharma
I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More
Reviewed By:
Vaibhav Shakya
Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More
Want to know More
Check our Editor Policy
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.
